- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Baan enters healthcare with Hiscom purchase
Baan enters healthcare with Hiscom purchaseVanenberg Ventures-the privately held investment arm of enterprise resource planning (ERP) software developer Baan-has purchased Dutch healthcare information systems company Hiscom. Vandenberg Ventures
Baan enters healthcare with Hiscom purchase
Vanenberg Ventures-the privately held investment arm of enterprise resource planning (ERP) software developer Baan-has purchased Dutch healthcare information systems company Hiscom. Vandenberg Ventures and Baan are also based in the Netherlands.
One of Baan's goals with Hiscom is to broaden the firm's current electronic patient record software to allow physicians to manage the complete interaction with the patient by including capabilities such as patient registration, data analysis, laboratory test ordering, and scheduling, said Otto van der Tang, an eight-year Baan veteran who assumed the post of managing director of Hiscom following the acquisition. Support for the management of medical images is also planned, van der Tang said.
"We believe that PACS are going to be an important component of such a patient interaction management system, but we don't believe that we should be developing this product ourselves," he said.
The Dutch firm is in discussion with a PACS software developer for inclusion of its technology in the Hiscom product portfolio.
- Search again
- Homepage
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
